The Role of Immunometabolic Dysregulation in Obesity-Associated Cardiovascular Risk: A Narrative Review. Journal of Evidence-Based Medical Research, [S. l.], v. 2, n. 1, 2026. DOI: 10.66687/jebmr.2.1.2026.29. Disponível em: https://jebmr.com/index.php/home/article/view/jebmr2629. Acesso em: 9 aug. 2026.